2012 Current Cancer Dedicated to bringing the latest news and information on cancer diagnosis, treatment and prevention.


Changes in Circulating Tumor Cell Detection in Patients with Localized Breast Cancer Before and After Surgery

Advertiment

Sandri MT, Zorzino L, Cassatella MC, Bassi F, Luini A, Casadio C, Botteri E, Rotmensz N, Adamoli L, Nolè F.

Unit of Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, Milan, Italy, maria.sandri@ieo.it.

BACKGROUND: Few data exist on the potential role of circulating tumor cells (CTCs) in patients with operable breast cancer. If the presence of CTCs in early breast cancer could predict an increased risk for relapse, it might be an early marker for treatment efficacy and could help in deciding treatment continuation. METHODS: Thirty milliliters of peripheral blood was taken from 56 breast cancer patients before surgery and again 5 days after surgery, and the presence of CTCs was evaluated. In case of positivity of one of the perioperative samples, another sample was taken after 30 days. The presence of CTCs was assessed with the CellSearch System (Veridex, Warren, NJ). RESULTS: One to three CTCs were found in 16 (29%) of 56 patients before surgery, in 14 (30%) of 47 patients at day 5, and in 8 (30%) of 27 at day 30. No association with pathological characteristics was found, apart a borderline significant association between presence of CTCs at baseline and vascular invasion (P = 0.07). When we looked at concordance between CTCs at baseline and after day 5 (47 patients), we found 40% discordant samples (10 negative at baseline and positive at day 5, and 9 vice versa). CONCLUSIONS: This study provides evidence of the presence of CTCs in approximately 30% of patients with localized breast cancer both before and after surgery, with change from positive to negative and vice versa in 40% of cases. No association with the pathological variables was found, except for vascular invasion and presence of preoperative CTCs. Long-term follow-up will be required to understand the significance of these data.

Related Search

via ripamo,

Leave a Reply

Suggested Posts

Vaccine for metastatic breast, ovarian cancer shows promise Sa dri MT, Zorzi o L, Cassatella MC, Bassi F, Lui i A, Casadio C, Botteri E, Rotme sz N, Adamoli L, Nolè F. U it of Laboratory Medici e, Europea I stitute of O cology, Via Ripamo ti 435, Mila , Italy, maria.sa dri@ieo.it. BACKGROUND: Few data exist o the pote tial role of circulati g tumor cells (CTCs) i patie ts with operable breast ca cer. If the [...]. Posted February 9th, 2010 | 3:01 am
Fungal Toxins Found in Urine of Young Girls Could Impact Future Risk of Breast Cancer Sa dri MT, Zorzi o L, Cassatella MC, Bassi F, Lui i A, Casadio C, Botteri E, Rotme sz N, Adamoli L, Nolè F. U it of Laboratory Medici e, Europea I stitute of O cology, Via Ripamo ti 435, Mila , Italy, maria.sa dri@ieo.it. BACKGROUND: Few data exist o the pote tial role of circulati g tumor cells (CTCs) i patie ts with operable breast ca cer. If the [...]. Posted February 9th, 2010 | 3:01 am
Blue Shield of California won’t cover the breast cancer drug Avastin Sa dri MT, Zorzi o L, Cassatella MC, Bassi F, Lui i A, Casadio C, Botteri E, Rotme sz N, Adamoli L, Nolè F. U it of Laboratory Medici e, Europea I stitute of O cology, Via Ripamo ti 435, Mila , Italy, maria.sa dri@ieo.it. BACKGROUND: Few data exist o the pote tial role of circulati g tumor cells (CTCs) i patie ts with operable breast ca cer. If the [...]. Posted February 9th, 2010 | 3:01 am
Boehringer Ingelheim Broadens its Breast Cancer Trial Programme for Afatinib Sa dri MT, Zorzi o L, Cassatella MC, Bassi F, Lui i A, Casadio C, Botteri E, Rotme sz N, Adamoli L, Nolè F. U it of Laboratory Medici e, Europea I stitute of O cology, Via Ripamo ti 435, Mila , Italy, maria.sa dri@ieo.it. BACKGROUND: Few data exist o the pote tial role of circulati g tumor cells (CTCs) i patie ts with operable breast ca cer. If the [...]. Posted February 9th, 2010 | 3:01 am
Targeted Therapies in Breast Cancer – Oxford American Pocket Notes Sa dri MT, Zorzi o L, Cassatella MC, Bassi F, Lui i A, Casadio C, Botteri E, Rotme sz N, Adamoli L, Nolè F. U it of Laboratory Medici e, Europea I stitute of O cology, Via Ripamo ti 435, Mila , Italy, maria.sa dri@ieo.it. BACKGROUND: Few data exist o the pote tial role of circulati g tumor cells (CTCs) i patie ts with operable breast ca cer. If the [...]. Posted February 9th, 2010 | 3:01 am